Moreover, with this study, we provide insights into the crosstalk between epigenetic and post-translational mechanisms governing FN-RMS tumorigenesis and add evidence to the potential of a differentiation therapy in this tumor subtype. The gene discussed is FN1; the disease is neoplasm.